G1 Therapeutics Inc (GTHX)
4.13
+0.36
(+9.55%)
USD |
NASDAQ |
May 01, 16:00
4.13
0.00 (0.00%)
Pre-Market: 08:15
G1 Therapeutics Max Drawdown (5Y): 97.24% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 97.24% |
| March 31, 2024 | 97.24% |
| February 29, 2024 | 97.24% |
| January 31, 2024 | 97.24% |
| December 31, 2023 | 97.24% |
| November 30, 2023 | 97.24% |
| October 31, 2023 | 97.24% |
| September 30, 2023 | 96.99% |
| August 31, 2023 | 96.47% |
| July 31, 2023 | 96.47% |
| June 30, 2023 | 96.38% |
| May 31, 2023 | 96.38% |
| April 30, 2023 | 96.38% |
| March 31, 2023 | 96.22% |
| February 28, 2023 | 95.09% |
| January 31, 2023 | 94.06% |
| December 31, 2022 | 94.06% |
| November 30, 2022 | 94.06% |
| October 31, 2022 | 94.06% |
| September 30, 2022 | 94.06% |
| August 31, 2022 | 94.06% |
| July 31, 2022 | 94.06% |
| June 30, 2022 | 94.06% |
| May 31, 2022 | 93.73% |
| April 30, 2022 | 92.44% |
| Date | Value |
|---|---|
| March 31, 2022 | 88.82% |
| February 28, 2022 | 87.17% |
| January 31, 2022 | 87.17% |
| December 31, 2021 | 86.66% |
| November 30, 2021 | 86.66% |
| October 31, 2021 | 86.66% |
| September 30, 2021 | 86.66% |
| August 31, 2021 | 86.66% |
| July 31, 2021 | 86.66% |
| June 30, 2021 | 86.66% |
| May 31, 2021 | 86.66% |
| April 30, 2021 | 86.66% |
| March 31, 2021 | 86.66% |
| February 28, 2021 | 86.66% |
| January 31, 2021 | 86.66% |
| December 31, 2020 | 86.66% |
| November 30, 2020 | 86.66% |
| October 31, 2020 | 86.66% |
| September 30, 2020 | 86.66% |
| August 31, 2020 | 86.66% |
| July 31, 2020 | 86.66% |
| June 30, 2020 | 86.66% |
| May 31, 2020 | 86.66% |
| April 30, 2020 | 86.66% |
| March 31, 2020 | 86.66% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
78.81%
Minimum
May 2019
97.24%
Maximum
Oct 2023
89.12%
Average
86.66%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
| Amicus Therapeutics Inc | 74.97% |
| Geron Corp | 86.09% |
| Palatin Technologies Inc | 96.46% |
| Oragenics Inc | 98.92% |
| TG Therapeutics Inc | 93.19% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -50.44 |
| Beta (5Y) | 1.710 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 104.5% |
| Historical Sharpe Ratio (5Y) | -0.3002 |
| Historical Sortino (5Y) | -0.7361 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 37.31% |